Immunohistochemical evidence for mesothelial origin of paratesticular adenomatoid tumour
- 1 February 2000
- journal article
- research article
- Published by Wiley in Histopathology
- Vol. 36 (2), 109-115
- https://doi.org/10.1046/j.1365-2559.2000.00825.x
Abstract
To investigate the histogenesis of paratesticular adenomatoid tumour by use of immunohistochemical markers for a variety of carcinomas and mesothelioma. Immunohistochemical staining of sections from 12 cases of paratesticular adenomatoid tumour was undertaken using primary antibodies to antigens expressed by benign epithelial cells and carcinoma (cytokeratin AE1/AE3, cytokeratin 34ßE12, epithelial membrane antigen, MOC-31, Ber-EP4, CEA, B72.3, LEA.135, Leu M1), stromal and vascular markers (vimentin, CD34, factor VIII), and mesothelioma-associated antigens (thrombomodulin, HBME-1, OC 125) and p53 protein. There was absence of immunohistochemical expression of epithelial/carcinoma markers MOC-31, Ber-EP4, CEA, B72.3, LEA.135, Leu M1 and to factor VIII and CD34. All tumours expressed cytokeratin AE1/AE3, epithelial membrane antigen and vimentin, with weak expression of cytokeratin 34ßE12 in 25% of tumours. Each tumour showed expression of thrombomodulin, HBME-1 and OC 125 in a membranous distribution. p53 protein expression was not detected. The immunohistochemical profile of paratesticular adenomatoid tumour is strongly supportive of a mesothelial cell origin.Keywords
This publication has 33 references indexed in Scilit:
- The Value of Antibodies 44-3A6, SM3, HBME-1, and Thrombomodulin in Differentiating Epithelial Pleural Mesothelioma From Lung AdenocarcinomaThe American Journal of Surgical Pathology, 1997
- Immunohistochemical phenotype of malignant mesothelioma: predictive value of CA125 and HBME‐1 expressionHistopathology, 1997
- Adenomatoid Tumors of the PleuraThe American Journal of Surgical Pathology, 1996
- Mesothelioma‐binding antibodies: thrombomodulin, OV 632 and HBME‐1 and their use in the diagnosis of malignant mesotheliomaHistopathology, 1996
- OV 632 and MOC 31 in the diagnosis of mesothelioma and adenocarcinoma: an assessment of their use in formalin fixed and paraffin wax embedded material.Journal of Clinical Pathology, 1995
- p53 immunostaining in the distinction between benign and malignant mesothelial proliferations using formalin‐fixed paraffin sectionsThe Journal of Pathology, 1992
- Immunoreactivity for p53 protein in malignant mesothelioma and non‐neoplastic mesotheliumThe Journal of Pathology, 1992
- Adenomatoid tumours: An immunohistochemical and ultrastructural appraisal of their htstogenestsThe Journal of Pathology, 1986
- The müllerian vestiges and benign epithelial tumours of the epididymisThe Journal of Pathology and Bacteriology, 1953